KCNA1 and Ataxia: EA1 would have been even less frequent, and so the molecular basis for gallic and tannic acid modulation of Kv1.1 to ameliorate ataxia would have relied upon beneficial modulation of wild-type Kv1.1 to treat ataxia for which the pathologic basis was not necessarily Kv1.1 dysfunction.